The American company Amparo, which specialises in the production of direct-fit prostheses, has acquired Adapttech, a pioneering Portuguese startup in intelligent prosthetic technology founded by Frederico Carpinteiro, an alumnus of the Integrated Master’s Degree in Bioengineering (MIB) – now the Master’s Degree in Bioengineering (M.BIO) – at the Faculty of Engineering of the University of Porto (FEUP).
With this acquisition, Frederico Carpinteiro becomes CEO of Amparo, a company that retains its name, and allows him to combine the data-based insights acquired by Adapttech with the physical fittings of the American company, while extending the services of both to 40 countries around the world, with a special future focus on Asia and the Middle East.
Amparo’s CEO, Frederico Carpinteiro.
Adapttech was the first company in the world to use 3D scanning with pressure measurements between the prosthesis and the stump to improve the fit of lower limb prostheses, reducing pain and bringing numerous advantages to amputees and also to prosthesis clinics.
For the FEUP alumnus, the merger of the two companies allows him to take this differentiated solution to more international markets. ‘This agreement opens up huge growth opportunities and allows us to reach more people faster, significantly amplifying the impact of our technologies. The focus remains on internationalisation, our aim is to strengthen our presence in the markets by offering better quality products to meet users’ needs.’
The combination of the two companies will have 16 people specialising in the areas of mechanical and biomedical engineering, operations, communication and management, and will enhance growth and solidify the company as a trusted partner for amputees and healthcare providers around the world.
Founded in 2016, Adapttech is a graduate startup from the University of Porto’s Science and Technology Park (UPTEC), and has received a total of 7.3 million euros in investment rounds over the past nine years.